MX2012000006A - L-serina para usarse como un farmaco para prevenir y/o tratar una respuesta inflamatoria de la piel. - Google Patents

L-serina para usarse como un farmaco para prevenir y/o tratar una respuesta inflamatoria de la piel.

Info

Publication number
MX2012000006A
MX2012000006A MX2012000006A MX2012000006A MX2012000006A MX 2012000006 A MX2012000006 A MX 2012000006A MX 2012000006 A MX2012000006 A MX 2012000006A MX 2012000006 A MX2012000006 A MX 2012000006A MX 2012000006 A MX2012000006 A MX 2012000006A
Authority
MX
Mexico
Prior art keywords
serine
drug
treating
preventing
inflammatory response
Prior art date
Application number
MX2012000006A
Other languages
English (en)
Inventor
Corinne Dechelette
Nathalie Castex Rizzi
Laetitia Bonzom
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MX2012000006A publication Critical patent/MX2012000006A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Abstract

La invención se relaciona con el uso de la L-serina como un fármaco para prevenir y/o tratar una respuesta inflamatoria de la piel causada por la sobreexpresión y/o la sobreactivación de los receptores PAR2.
MX2012000006A 2009-07-01 2010-07-01 L-serina para usarse como un farmaco para prevenir y/o tratar una respuesta inflamatoria de la piel. MX2012000006A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0954497A FR2947452B1 (fr) 2009-07-01 2009-07-01 L-serine et/ou l-asparagine et/ou l-valine pour prevenir et/ou au traiter des reactions inflammatoires de la peau.
PCT/EP2010/059401 WO2011000930A1 (fr) 2009-07-01 2010-07-01 L-sérine pour son utilisation en tant que médicament pour prévenir et/ou traiter une réaction inflammatoire de la peau

Publications (1)

Publication Number Publication Date
MX2012000006A true MX2012000006A (es) 2012-04-02

Family

ID=41381620

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000006A MX2012000006A (es) 2009-07-01 2010-07-01 L-serina para usarse como un farmaco para prevenir y/o tratar una respuesta inflamatoria de la piel.

Country Status (18)

Country Link
US (1) US10052297B2 (es)
EP (1) EP2448570B1 (es)
JP (1) JP2012531457A (es)
KR (1) KR20120089231A (es)
CN (1) CN102470119A (es)
AU (1) AU2010267964B2 (es)
BR (1) BRPI1011912A2 (es)
CA (1) CA2766706C (es)
FR (1) FR2947452B1 (es)
IL (1) IL217281A0 (es)
MA (1) MA33457B1 (es)
MX (1) MX2012000006A (es)
NZ (1) NZ597905A (es)
RU (1) RU2554482C2 (es)
TN (1) TN2011000669A1 (es)
UA (1) UA107666C2 (es)
WO (1) WO2011000930A1 (es)
ZA (1) ZA201200608B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3246B1 (ar) 2009-09-09 2018-03-08 Regeneron Pharma اجسام مضادة بشرية ذات ألفة تفاعل عالية مع مستقبل 2 المفعل بالبروتين البشري
FR3015291B1 (fr) * 2013-12-23 2016-06-24 Laboratoires Dermatologiques D'uriage Composition antiprurigineuse
FR3016127B1 (fr) * 2014-01-07 2017-05-12 Laboratoires Dermatologiques D'uriage Composition pour la restauration de l'effet barriere des cellules epitheliales
JP2015137249A (ja) * 2014-01-22 2015-07-30 株式会社ファンケル 冬季うつ病の改善剤
JP6324777B2 (ja) * 2014-03-18 2018-05-16 ポーラ化成工業株式会社 コラーゲン産生促進剤
AU2016208545A1 (en) * 2015-01-23 2017-06-15 Société des Produits Nestlé S.A. Treatment or prevention of inflammation using serine
FR3039404B1 (fr) * 2015-07-27 2020-03-13 Laboratoires Dermatologiques D'uriage Composition cosmetique et/ou dermatologique et/ou therapeutique comprenant des archees pour la stimulation du systeme humain de reconnaissance immunitaire
FR3039405B1 (fr) * 2015-07-27 2021-08-27 Laboratoires Dermatologiques Duriage Composition cosmetique et/ou dermatologique et/ou therapeutique pour la stimulation du systeme humain de reconnaissance immunitaire
FR3064177B1 (fr) * 2017-03-23 2021-07-23 Laboratoires Dermatologiques Duriage Composition cosmetique et/ou dermatologique destinee au traitement des dermatoses inflammatoires prurigineuses
EP4309642A1 (en) * 2021-03-19 2024-01-24 Astrogen, Inc. Liquid preparation of l-serine or pharmaceutically acceptable salt thereof and method for preparing same
CN115105423B (zh) * 2022-07-18 2023-12-22 深圳浦瑞健康科技有限公司 具有抗炎抗敏活性的组合物及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5425954A (en) * 1993-09-30 1995-06-20 Curafas Incorporated Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
JPH08217695A (ja) * 1995-02-10 1996-08-27 Pola Chem Ind Inc 皮膚外用剤
CN1054505C (zh) * 1996-12-11 2000-07-19 林镇才 一种活性成份的化妆品添加剂
JPH1160435A (ja) * 1997-08-20 1999-03-02 Shiseido Co Ltd 肌荒れ改善用化粧料
JP3645082B2 (ja) * 1997-11-21 2005-05-11 株式会社カネボウ化粧品 セラミド合成促進剤
EP1070727A1 (en) * 1999-03-01 2001-01-24 Aventis Pharma Deutschland GmbH Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
JP2001278796A (ja) 2000-03-28 2001-10-10 Yamamoto Koryo Kk 抗痒み・抗アレルギー組成物
JP2004518715A (ja) * 2001-02-09 2004-06-24 フィジシャンズ チョイス オブ アリゾナ， インコーポレイテッド 先端線維性軟ゆうの緩和
JP2002316929A (ja) 2001-04-18 2002-10-31 Japan Science & Technology Corp Ｌ−セリン又はグリシンからなる抗アポトーシス剤
JP2003089658A (ja) * 2001-09-19 2003-03-28 Noevir Co Ltd 抗痒み効果に優れる皮膚外用剤並びに食品
JP2004170323A (ja) * 2002-11-22 2004-06-17 Sumitomo Pharmaceut Co Ltd 皮膚疾患治療剤のスクリーニング方法
JP2005040403A (ja) * 2003-07-23 2005-02-17 Shiseido Co Ltd 敏感肌のための美容施術方法
BG65694B1 (bg) * 2003-12-31 2009-07-31 Владимир НАЙДЕНОВ Средство за лечение на дерматози
FI121915B (fi) * 2004-02-06 2011-06-15 Neurofood Ab Oy Koostumus psoriasiksen hoitoon
US9089576B2 (en) * 2004-04-30 2015-07-28 Laboratoires Expanscience Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
US7547434B2 (en) * 2005-09-09 2009-06-16 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for mitigating skin irritation
JP2007084460A (ja) * 2005-09-20 2007-04-05 Tokiwa Yakuhin Kogyo Kk 美肌用組成物
FR2892410B1 (fr) * 2005-10-21 2010-10-15 Fabre Pierre Dermo Cosmetique Nouveaux hydro-acides gras insatures et leur utilisation dermo cosmetologique
WO2007076055A2 (en) * 2005-12-22 2007-07-05 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
DE602006013787D1 (de) * 2006-03-28 2010-06-02 Epitech Group Srl Eine Pharmazeutische Zusammensetzung zur Behandlung von Pathologien, die durch die allgemeine Immunantwort verursacht werden
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
KR20100095447A (ko) * 2007-12-27 2010-08-30 카오카부시키가이샤 여드름 피부용 피부 외용제
FR2938193B1 (fr) * 2008-11-07 2011-08-12 Expanscience Lab Medicament ou composition dermatologique comprenant un extrait peptidique d'avocat destine au traitement et a la prevention du prupit
US9421262B2 (en) * 2009-10-28 2016-08-23 Biomed Research & Technologies, Inc. Compositions and methods for treating dermatological conditions

Also Published As

Publication number Publication date
TN2011000669A1 (fr) 2013-05-24
AU2010267964B2 (en) 2014-02-27
US20120172446A1 (en) 2012-07-05
WO2011000930A1 (fr) 2011-01-06
CN102470119A (zh) 2012-05-23
FR2947452A1 (fr) 2011-01-07
JP2012531457A (ja) 2012-12-10
UA107666C2 (uk) 2015-02-10
RU2012102826A (ru) 2013-08-10
CA2766706C (fr) 2018-02-27
US10052297B2 (en) 2018-08-21
EP2448570B1 (fr) 2016-11-16
NZ597905A (en) 2014-01-31
CA2766706A1 (fr) 2011-01-06
ZA201200608B (en) 2014-06-25
KR20120089231A (ko) 2012-08-09
FR2947452B1 (fr) 2012-04-20
RU2554482C2 (ru) 2015-06-27
MA33457B1 (fr) 2012-07-03
IL217281A0 (en) 2012-02-29
EP2448570A1 (fr) 2012-05-09
AU2010267964A1 (en) 2012-02-23
BRPI1011912A2 (pt) 2016-04-19

Similar Documents

Publication Publication Date Title
MX2012000006A (es) L-serina para usarse como un farmaco para prevenir y/o tratar una respuesta inflamatoria de la piel.
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
MX2012010404A (es) Inhibidores heterociclicos de los receptores de histamina para el tratamiento de enfermedades.
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
MX2013005356A (es) Uso de fluopyram para combatir nematodos en cultivos.
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
UA106764C2 (uk) Похідні n1-сульфоніл-5-фторпіримідинону
MX2012001618A (es) Derivados de 5-fluoropirimidinona.
EA201201648A1 (ru) Стимуляторы sgc
MX338489B (es) Derivados de hidantoina utiles como inhibidores de kv3.
IN2012DN00624A (es)
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
IN2015DN01151A (es)
MX353299B (es) Metodos y composiciones relacionadas con p62 para el tratamiento y profilaxis del cancer.
PH12014501032A1 (en) 2-thiopyrimidinones
ZA201304868B (en) Treatment of pain associated with dislocation of basal endometrium
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
MX2015003701A (es) Composiciones para tratamiento.
MX348397B (es) Uso de extractos de filipendula para el tratamiento y profilaxis de dolor crónico.
EA201270728A1 (ru) Пуриновые соединения
IN2014CN03625A (es)
CY1119470T1 (el) Γαλακταγωγες συνθεσεις με βαση φωσφατιδυλοσερινη
MX363385B (es) Métodos para el tratamiento de enfermedad de células falciformes y otras condiciones inflamatorias.
MX362854B (es) Siarn y su uso en los metodos y composiciones para el tratamiento y/o prevencion de enfermedades de los ojos.
MX2011013324A (es) Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor.

Legal Events

Date Code Title Description
FG Grant or registration